Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homologous recombination based gene therapy

L W Lai1, Y H Lien

  • 1Department of Medicine, Sections of Endocrinology and Nephrology, University of Arizona Health Sciences Center, Tucson, Ariz. 95724, USA. llai@u.arizona.edu

Experimental Nephrology
|January 20, 1999
PubMed
Summary

Homologous recombination gene therapy shows promise for treating genetic diseases by enabling permanent, regulated gene expression. Further in vivo testing is warranted for this powerful therapeutic approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From childhood onset lymphedema to fatal fetal hydrops: Possible modifying genes for a FOXC2 mutation.

Lymphology·2018
Same author

Renal gene therapy.

Methods in molecular medicine·2011
Same author

pANCA-positive microscopic polyangiitis in a patient with IgM monoclonal gammopathy.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Influence of oxygen defects on the crystal structure and magnetic properties of the (Tb1-xNax)MnO3-y (0<or=x<or=0.3) system.

Inorganic chemistry·2007
Same author

Chemical size effect on the magnetic and electrical properties in the (Tb(1-)(x)Eu(x))MnO(3) (0 < or = x < or = 1.0) system.

The journal of physical chemistry. B·2007
Same author

Unexpected diagnosis of fabry disease in an 80-year-old man with syncope.

Cardiology·2001

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Current gene therapy vectors often fail to achieve sufficient transgene expression for treating genetic diseases.
  • Homologous recombination (HR) was previously limited by low frequency in mammalian cells but is now a viable gene therapy strategy.

Purpose of the Study:

  • To review recent advancements in homologous recombination for gene therapy applications.
  • To assess the potential of HR-based strategies for overcoming limitations in current gene therapy protocols.

Main Methods:

  • Review of six recent studies on homologous recombination in mammalian cells.
  • Analysis of various HR-enhancing approaches, including RNA/DNA chimeric oligonucleotides, homologous DNA fragments, and adeno-associated viral vectors.

Related Experiment Videos

Main Results:

  • Several studies demonstrate a promising frequency of homologous recombination in mammalian cells.
  • The observed frequencies suggest that HR-based gene therapy is suitable for further in vivo investigation.

Conclusions:

  • Homologous recombination-based gene therapy holds significant potential as a therapeutic modality for genetic disorders.
  • HR offers the possibility of permanent, regulated gene expression and correction, applicable to dominant inherited diseases like polycystic kidney disease.